Aggregator

A vulnerability has been found in Google Chrome and classified as critical. Impacted is an unknown function of the component Fonts. The manipulation leads to integer overflow. This vulnerability is listed as CVE-2026-11299. The attack may be initiated remotely. There is no available exploit. The affected component should be upgraded.

A vulnerability was found in Google Chrome and classified as problematic. The affected element is an unknown function of the component Permissions. The manipulation results in improper restriction of rendered ui layers. This vulnerability is cataloged as CVE-2026-11300. The attack may be launched remotely. There is no exploit available. It is suggested to upgrade the affected component.

A vulnerability was found in Google Chrome. It has been classified as problematic. The impacted element is an unknown function of the component LiveCaption. This manipulation causes out-of-bounds read. This vulnerability is registered as CVE-2026-11301. Remote exploitation of the attack is possible. No exploit is available. Upgrading the affected component is recommended.

A vulnerability was found in Google Chrome. It has been rated as critical. This impacts an unknown function of the component PDFium. Performing a manipulation results in use after free. This vulnerability is reported as CVE-2026-11304. The attack is possible to be carried out remotely. No exploit exists. Upgrading the affected component is advised.

A vulnerability categorized as critical has been discovered in Google Chrome on iOS. Impacted is an unknown function. Such manipulation leads to improper access controls. This vulnerability is documented as CVE-2026-11302. The attack can be executed remotely. There is not any exploit available. It is advisable to upgrade the affected component.

A vulnerability marked as critical has been reported in Google Chrome. This affects an unknown function of the component Extensions. The manipulation leads to improper privilege management. This vulnerability is traded as CVE-2026-11308. It is possible to initiate the attack remotely. There is no exploit available. It is suggested to upgrade the affected component.

A vulnerability, which was classified as problematic, was found in Google Chrome on iOS. This affects an unknown part. Executing a manipulation can lead to permissive cross-domain policy with untrusted domains. The identification of this vulnerability is CVE-2026-11298. The attack may be launched remotely. There is no exploit available. You should upgrade the affected component.

A vulnerability classified as problematic was found in OpenStack Ironic up to 35.0.1. The affected element is an unknown function of the component API/JSON-RPC Service. Such manipulation leads to allocation of resources. This vulnerability is listed as CVE-2026-50589. The attack may be performed from remote. There is no available exploit.

A vulnerability described as critical has been identified in Google Chrome on Android. This affects an unknown part of the component WebView. The manipulation results in improper privilege management. This vulnerability is identified as CVE-2026-11295. The attack can be executed remotely. There is not any exploit available. Upgrading the affected component is recommended.

2026年5月，全国受理网络违法和不良信息举报1799.4万件

公安部12日在京召开新闻发布会，通报当前电信网络诈骗犯罪的最新形势、特点，提示防范电信网络诈骗要点，进一步提升全社会识诈防诈反诈意识，推动构建全民反诈、全社会反诈的坚固防线。

国家网信办有关负责人表示，该《公约》的制定发布，有利于凝聚行业共识，强化行业自律，加强涉企侵权信息治理，进一步优化营商网络环境，保护企业和企业家网络合法权益。下一步，将加强对网站平台的指导督促，扎实推动《公约》落地见效。

《报告》以习近平总书记关于网络强国的重要思想为根本遵循，全面梳理2025年我国个人信息保护取得的成果，系统总结经验，广泛凝聚共识。这是国家网信办首次发布个人信息保护综合性年度报告……

近年来，国家安全机关工作发现，境外间谍情报机关通过多种新型间谍设备，持续搜集窃取我海洋敏感数据。

金融业务具有并发量大、连续性强与资金敏感性高等特点，需严格遵循安全合规要求。智能体相关技术应用的引入，为金融行业带来了全新的系统性安全挑战。因此，亟须对智能体技术在金融业务应用中可能引发的安全风险进行系统梳理与深入分析……

Danish pharmaceutical giant Novo Nordisk, the world's largest producer of insulin, disclose

Danish pharmaceutical giant Novo Nordisk, the world's largest producer of insulin, disclosed a data breach affecting patient information from some clinical trials. [...]

泰国和韩国等国以整容和试管婴儿等医疗服务闻名，而中国正试图通过提供先进的癌症疗法吸引全世界的医疗游客。患者出国就医主要是两大原因：先进疗法的可得性，以及价格。CAR-T 疗法是肿瘤学领域最有前景的突破性疗法之一，但大部分国家或者无法提供，或者价格太高。该疗法首要先从患者血液中采集 T 细胞，然后在实验室中基因改造，使其产生特殊的 CAR 受体，该受体能与癌细胞上的特定蛋白质结合。经过基因改造的细胞随后被大量增殖，重新输回患者体内。CAR-T 细胞会主动寻找并杀死携带靶抗原的癌细胞。美国癌症协会称，美国的单次输注 CAR-T 细胞费用在 30-47.5 万美元之间。而中国的费用约为 15-18 万美元，且价格可能还会更低。中国药品监管机构最近批准了一个定价低于 30 万元人民币的免疫疗法上市申请。纽约 Market Research Future 预测，中国医疗旅游市场规模预计将从 2025 年的 13 亿美元增长到 2035 年的 34 亿美元。Mercator Institute for China Studies 的分析师 Jeroen Groenewegen-Lau 称，很多先进的疗法是在中国研发的，但对于中国现有的医疗体系和患者支付能力而言，这些疗法太超前，因此融入国际医疗体系符合中国的利益。

[ITA] Un recente (circa 10 giorni fa) aggiornamento dei nostri servizi di posta pare stia caus